Algorae Pharmaceuticals Limited (ASX:1AI)
Australia · Delayed Price · Currency is AUD 0.0120
-0.0005 (-4.00%)
Jul 15, 2026, 11:09 AM AEST
Algorae Pharmaceuticals Market Cap
Algorae Pharmaceuticals has a market cap or net worth of 25.32 million as of July 14, 2026. Its market cap has increased by 150.09% in one year.
Market Cap
25.32M
Enterprise Value
23.44M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since September 1, 2004, Algorae Pharmaceuticals's market cap has increased from 12.17M to 25.32M, an increase of 108.08%. That is a compound annual growth rate of 3.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 25.32M | 7.09% |
| Dec 31, 2025 | 23.64M | 133.52% |
| Dec 30, 2024 | 10.12M | -39.06% |
| Dec 29, 2023 | 16.61M | 7.70% |
| Dec 30, 2022 | 15.42M | 185.23% |
| Dec 30, 2021 | 5.41M | -32.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurizon Therapeutics | 50.00M |
| Imugene | 40.75M |
| Proteomics International Laboratories | 30.56M |
| Patrys | 26.66M |
| Noxopharm | 26.12M |
| NeuroScientific Biopharmaceuticals | 23.61M |
| Neurotech International | 21.08M |
| EZZ Life Science Holdings | 20.47M |